CStone’s Anti-CTLA-4 Antibody CS1002 Filed for Clinical Trial Approval in Australia Dec 29, 2017 Life Science
Shanghai Henlius Announces $192.5 Million Funding for Biosimilars, Novel mAbs Dec 29, 2017 Life Science
Cellular Biomedicine Group Announces Closing of $14.5M Private Placement Offering Dec 28, 2017 Life Science
Shanghai’s SARI to Acquire NMS, an Italian Oncology Company, for $359 Million Dec 28, 2017 Life Science
Big tech’s spending on healthcare equity deals up 875% in 5 years: What 5 tech giants are up to Dec 27, 2017 Life Science
DelMar Pharmaceuticals Announces Fast Track Designation for VAL-083 in Recurrent Glioblastoma Dec 27, 2017 Life Science
Nanjing Legend Lands $350 Million Upfront for CAR-T Partnership with Janssen Dec 22, 2017 Life Science
